JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glazko, A. J.
Right arrow Articles by Bratton, A. C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Glazko, A. J.
Right arrow Articles by Bratton, A. C., Jr.
Journal of Pharmacology And Experimental Therapeutics, Vol. 96, Issue 4, 445-459, 1949
Copyright © 1949 by American Society for Pharmacology and Experimental Therapeutics


BIOCHEMICAL STUDIES ON CHLORAMPHENICOL (CHLOROMYCETIN)

II. Tissue Distribution and Excretion Studies

Anthony J. Glazko 1, Loretta M. Wolf 1, Wesley A. Dill 1, and A. Calvin Bratton Jr. 1

1 Research Laboratories of Parke, Davis and Company, Detroit, Michigan

Chloramphenicol is rapidly absorbed, metabolized and excreted. In man the major route of excretion is by way of the kidneys, with approximately 90 per cent of the administered dose accounted for in 24 hours. Lesser amounts are excreted in the urine of lower animals. The bulk of the excreted drug is in the form of an inactive nitro compound, and less than 10 per cent of the administered dose is excreted unchanged. Renal plasma clearance figures indicate that chioramphenicol is largely excreted by glomerular filtration, while the inactive metabolic products appear to be excreted mainly by tubular secretion.

In the rat, parenteral administration of chioramphenicol results in excretion into the intestine by way of the bile, principally as inactive nitro compounds. These may be partly reabsorbed, or reduced in the intestine to form aryl amines which are excreted in the feces. Inactivation of chioramphenicol occurs in vitro with minced liver preparations, with the production of inactive nitro compounds and small amounts of aryl amines. The distribution of chloramphenicol in the tissues is not uniform, with high concentrations being found in the liver and kidneys and low concentrations in the brain and spinal fluid.

Submitted on April 25, 1949




This article has been cited by other articles:


Home page
Arch Intern MedHome page
C. M. KUNIN and M. FINLAND
Restrictions Imposed on Antibiotic Therapy by Renal Failure
Arch Intern Med, December 1, 1959; 104(6): 1030 - 1050.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1949 by the American Society for Pharmacology and Experimental Therapeutics.